Hangzhou Tigermed Consulting Co., Ltd · 泰格医药
Last · HKSEHK$41.66+0.16 (+0.39%)live · yahoo · 3h ago
Market capHK$35.9B123.1M sh
P/E · TTM347fwd 31.7 · eps 0.12
Beta0.43vs S&P 500
Div yield0.30%annual · TTM
52w range
HK$28.12HK$57.00
Volume1.1Msession
| Revenue | ¥7.3B |
|---|---|
| Operating income | ¥-37.9M |
| Net income | ¥-413.2M |
| Operating margin | -0.5% |
| Net margin | -5.7% |
| Return on equity | -2.0% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2025-04-29
- Current Ratio Low
- Rd Intensity High
Red flags
- Current Ratio Low — Current ratio 0.00
- Rd Intensity High — R&D/Revenue 100.7%
Earnings transcripts
Documents
FormReporting forFiledFlags